CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

What Does the Genetic Testing Landscape Look Like?

What Does the Genetic Testing...

Scopus BioPharma Makes New Management Appointment Following the Acquisition of Chief Immunotherapy Firm

Scopus BioPharma Makes New Management...

The Impact of AI and ML in Genomics

The Impact of AI and ML in Genomics

Lykan Bioscience Collaborates with Vineti to Take Cell-Based Therapies from the Clinic to the Market

Lykan Bioscience Collaborates with...

Singapore to grow into a global hub of biotechnology

Singapore to grow into a global hub...

US FDA Award VICO with Therapeutics Orphan-Drug Designation for VO659

US FDA Award VICO with Therapeutics...

An Insight into What Genome is

An Insight into What Genome is

Human Genomics Projections for the Future

Human Genomics Projections for the...

What Does the Genetic Testing Landscape Look Like?

What Does the Genetic Testing...

Scopus BioPharma Makes New Management Appointment Following the Acquisition of Chief Immunotherapy Firm

Scopus BioPharma Makes New Management...

The Impact of AI and ML in Genomics

The Impact of AI and ML in Genomics

Lykan Bioscience Collaborates with Vineti to Take Cell-Based Therapies from the Clinic to the Market

Lykan Bioscience Collaborates with...

Singapore to grow into a global hub of biotechnology

Singapore to grow into a global hub...

US FDA Award VICO with Therapeutics Orphan-Drug Designation for VO659

US FDA Award VICO with Therapeutics...

An Insight into What Genome is

An Insight into What Genome is

Human Genomics Projections for the Future

Human Genomics Projections for the...

How Data Science is Revolutionizing Genomics

Life Sciences Review | Tuesday, January 25, 2022
Tweet

Improvement in the drug discovery or clinical trial process with technologies like big data can speed up the time it takes to bring a potentially life-saving drug to market.


FREMONT, CA: The human body is full of genetic information. The DNA is made up of around three billion genetic bases, and if all the DNA in the human body were laid out, it would extend to twice the diameter of the Solar System, with every cell's DNA being three meters long.


Data, information, and statistics are driving biotechnology ahead, which uses living creatures or biological systems and their derivatives to manufacture products. Bioinformatics has evolved from a tool in the inventory of a biologist or biotechnologist to a discipline.


Business intelligence, data analytics, and technical advancements are critical for the emergence of new technologies and treatments and resolving current issues. Healthcare researchers can find potential drug targets, optimize processes, bring novel drugs to market, and minimize clinical trial errors by making sense of massive data derived from genomics or sensors.


Genomics


If people consider big data in terms of biotechnology, the first thing that comes to mind is probably genome sequencing. The Human Genome Project was a ground-breaking project that offered access to three billion bases of data, allowing researchers to learn more about mutations, genes, and other topics.


Researchers can now use the data to gain significant insights in fields such as medicine, crime scene investigations, and so on. Data scientists employ frameworks and tools to store, monitor, receive, analyze, and interpret data in order to work successfully with it. Tools to automatically annotate individual genes are currently being developed, and software companies have begun to tackle genome interpretation.


Drug discovery, development and genomics


The process of bringing a novel pharmaceutical product to market is long and complicated, with numerous bottlenecks. Trials frequently fail to reach their objectives, such as enrolment, causing additional delays and increasing the expense of an already costly procedure. Before scientists can start enrolling patients for a clinical trial, they must first discover a drug candidate, which requires a lot of data, experiments, and evaluation of risk/benefit.


Researchers can now screen millions of compounds with automated software to find drug candidates for clinical trials. Pharmaceutical experts might delegate the difficult task of sorting through a vast library of prospective drugs and determining what is likely to succeed based on the trial's unique criteria to artificial intelligence (AI).


Any advancement in the drug discovery or clinical trial process can save millions of dollars in development expenditures and, as a result, minimize the time it takes to bring potentially life-saving treatment to market.


See Also:TOP 10 ACCOUNTS PAYABLE SOLUTION COMPANIES


Weekly Brief

loading
Top 10 Genomics Solution Companies in Europe - 2021
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/how-data-science-is-revolutionizing-genomics--nwid-432.html